Ma G, Jin Y
Pharm Biol. 2024; 62(1):803-817.
PMID: 39460586
PMC: 11514402.
DOI: 10.1080/13880209.2024.2415643.
Ren X, Wang Y, He R, Dong F, Liu D, Yang T
BMJ Open. 2023; 13(6):e071560.
PMID: 37277221
PMC: 10254868.
DOI: 10.1136/bmjopen-2023-071560.
Zou R, Nouraie S, Rossiter H, McDonald M, DeMeo D, Mason S
Chronic Obstr Pulm Dis. 2023; 10(1):112-121.
PMID: 36599111
PMC: 9995230.
DOI: 10.15326/jcopdf.2022.0365.
Ibeneme S, Ativie R, Ibeneme G, Myezwa H, Ezuma A, Nnamani A
Arch Public Health. 2022; 80(1):213.
PMID: 36138426
PMC: 9502601.
DOI: 10.1186/s13690-022-00967-3.
Liu G, Khan S, Colangelo L, Meza D, Washko G, Sporn P
Ann Intern Med. 2022; 175(8):1118-1125.
PMID: 35849828
PMC: 9673050.
DOI: 10.7326/M22-0205.
Symptomatic smokers without COPD have physiological changes heralding the development of COPD.
Bazzan E, Semenzato U, Turato G, Biondini D, Cubero P, Marin-Oto M
ERJ Open Res. 2022; 8(2).
PMID: 35769419
PMC: 9234424.
DOI: 10.1183/23120541.00202-2022.
Association Between Non-obstructive Chronic Bronchitis and Incident Chronic Obstructive Pulmonary Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis.
Wu F, Fan H, Liu J, Li H, Zeng W, Zheng S
Front Med (Lausanne). 2022; 8:805192.
PMID: 35145979
PMC: 8823696.
DOI: 10.3389/fmed.2021.805192.
CT pectoralis muscle area is associated with DXA lean mass and correlates with emphysema progression in a tobacco-exposed cohort.
OBrien M, Zou R, Hyre N, Leader J, Fuhrman C, Sciurba F
Thorax. 2021; 78(4):394-401.
PMID: 34853157
PMC: 9156725.
DOI: 10.1136/thoraxjnl-2021-217710.
COPD Diagnosis: Time for Disruption.
Wouters E, Breyer M, Breyer-Kohansal R, Hartl S
J Clin Med. 2021; 10(20).
PMID: 34682780
PMC: 8539379.
DOI: 10.3390/jcm10204660.
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Radicioni G, Ceppe A, Ford A, Alexis N, Barr R, Bleecker E
Lancet Respir Med. 2021; 9(11):1241-1254.
PMID: 34058148
PMC: 8570975.
DOI: 10.1016/S2213-2600(21)00079-5.
Bronchial Diseases are Insufficiently Defined with the Term COPD.
von Wichert P
Int J Chron Obstruct Pulmon Dis. 2021; 16:1349-1352.
PMID: 34025120
PMC: 8132574.
DOI: 10.2147/COPD.S298210.
Impaired Respiratory Health and Life Course Transitions From Health to Chronic Lung Disease.
Liu G, Kalhan R
Chest. 2021; 160(3):879-889.
PMID: 33865834
PMC: 8449011.
DOI: 10.1016/j.chest.2021.04.009.
Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.
Gelb A, Yamamoto A, Verbeken E, Hogg J, Tashkin D, Tran D
Chronic Obstr Pulm Dis. 2021; 8(1).
PMID: 33513660
PMC: 8047618.
DOI: 10.15326/jcopdf.2020.0176.
Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study.
Toren K, Schioler L, Lindberg A, Andersson A, Behndig A, Bergstrom G
BMJ Open Respir Res. 2020; 7(1).
PMID: 32759170
PMC: 7409993.
DOI: 10.1136/bmjresp-2020-000600.
Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.
Tanner L, Single A
J Innate Immun. 2019; 12(3):203-225.
PMID: 31527372
PMC: 7265725.
DOI: 10.1159/000502489.
Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV/FVC.
Hoesterey D, Das N, Janssens W, Buhr R, Martinez F, Cooper C
Respir Med. 2019; 156:58-68.
PMID: 31437649
PMC: 6768077.
DOI: 10.1016/j.rmed.2019.08.004.
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
Garudadri S, Woodruff P, Han M, Curtis J, Barr R, Bleecker E
Chest. 2019; 155(5):908-917.
PMID: 30684474
PMC: 6533449.
DOI: 10.1016/j.chest.2018.12.022.
Use of a Cross-Sectional Survey in the Adult Population to Characterize Persons at High-Risk for Chronic Obstructive Pulmonary Disease.
Pleasants R, Heidari K, Ohar J, Donohue J, Lugogo N, Richard C
Healthcare (Basel). 2019; 7(1).
PMID: 30669305
PMC: 6473439.
DOI: 10.3390/healthcare7010012.
Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort.
Perez-Padilla R, Wehrmeister F, Montes de Oca M, Lopez M, Jardim J, Muino A
Int J Chron Obstruct Pulmon Dis. 2018; 13:3549-3561.
PMID: 30464437
PMC: 6208535.
DOI: 10.2147/COPD.S175527.
COPD: time to improve its taxonomy?.
Celli B, Agusti A
ERJ Open Res. 2018; 4(1).
PMID: 29707563
PMC: 5912933.
DOI: 10.1183/23120541.00132-2017.
